Authors: GENEVOIS E LELOUER V VERCKEN JB CAILLON R

Citation: E. Genevois et al., STUDY DESIGN, METHODOLOGY AND STATISTICAL-ANALYSES IN THE CLINICAL DEVELOPMENT OF SPARFLOXACIN, Journal of antimicrobial chemotherapy, 37, 1996, pp. 65-72

Authors: RAVDIN PM BURRIS HA COOK G EISENBERG P KANE M BIERMAN WA MORTIMER J GENEVOIS E BELLET RE

Citation: Pm. Ravdin et al., PHASE-II TRIAL OF DOCETAXEL IN ADVANCED ANTHRACYCLINE-RESISTANT OR ANTHRACENEDIONE-RESISTANT BREAST-CANCER, Journal of clinical oncology, 13(12), 1995, pp. 2879-2885

Authors: SPIRO TE STEPHENS JWG GENEVOIS E HAAS J DOBBINS T

Citation: Te. Spiro et al., EXPLORATORY ANALYSIS OF THE RELATIONSHIP BETWEEN OBESITY AND OTHER RISK-FACTORS AND PRIMARY EFFICACY AND SAFETY OUTCOMES IN ENOXAPARIN STUDIES OF VENOUS THROMBOEMBOLIC DISEASE PREVENTION AFTER TOTAL HIP AND KNEE REPLACEMENT, Blood, 86(10), 1995, pp. 3691-3691